Nepafenac ophthalmic suspension 0.1% for the prevention and treatment of ocular inflammation associated with cataract surgery : Journal of Cataract & Refractive Surgery

Secondary Logo

Journal Logo

Article

Nepafenac ophthalmic suspension 0.1% for the prevention and treatment of ocular inflammation associated with cataract surgery

Lane, Stephen S. MD; Modi, Satish S. MD; Lehmann, Robert P. MD; Holland, Edward J. MD

Author Information
Journal of Cataract & Refractive Surgery 33(1):p 53-58, January 2007. | DOI: 10.1016/j.jcrs.2006.08.043

Abstract

© 2007 by Lippincott Williams & Wilkins, Inc.

Full Text Access for Subscribers:

You can read the full text of this article if you:

Access through Ovid